Considerations for Choosing a Primary Engineering Control for Compounding Sterile Products
Download in electronic PDF format for $75
Abstract: The introduction of United States Pharmacopeia (USP) Chapter <797> and the National Institute for Occupational Safety and Health (NIOSH) alert for preventing occupational exposure to hazardous drugs have renewed interest in engineering controls used for compounding sterile drugs. Engineering controls are engineered equipment or machinery that eliminate or reduce the potential exposure of a preparation or personnel to contamination or a hazard. Primary engineering controls are employed directly at the point of use. Examples of primary engineering controls used in aseptic compounding are laminar airflow workstations, biological safety cabinets, and barrier isolators. The design and construction of a facility contributes to protection of both the preparation and personnel, and thus is considered a secondary engineering control. Other secondary engineering controls include cleanrooms and negative-pressure containment rooms. This article reviews primary engineering controls along with a rationale for choosing one
Related Keywords:
primary engineering controls, laminar airflow workstations, biological safety cabinets, safety, containment, exposure prevention, hazardous materials, barrier isolators
Related Categories:
ENVIRONMENTAL , LEGAL, TECHNOLOGY, UNITED STATES PHARMACOPEIA CONVENTIONS, HAZARDOUS DRUGS
Printer-Friendly Version
| Related Articles from IJPC |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
Considerations for Choosing a Primary Engineering Control for Compounding Sterile Products
Wagner James T
|
Jul/Aug 2005
Pg. 284-290
|
Primary Engineering Controls in Pharmaceutical Compounding, Part 1: Unidirectional-airflow Workstations, Compounding Aseptic Isolators, and Compounding Aseptic Containment Isolators
Mulder Kyle
|
Nov/Dec 2019
Pg. 447-452
|
Primary Engineering Controls in Pharmaceutical Compounding, Part 2: Biosafety Cabinets
Mulder Kyle
|
Jan/Feb 2020
Pg. 7-12
|
Evaluation of Containment Ventilated Enclosure Performance in Absence of Negative Pressure Containment Secondary Engineering Control
Hutson Chad, Day A J
|
Nov/Dec 2019
Pg. 511-518
|
Compounding Enclosures: Ensuring Safety During the Preparation of Sterile and Nonsterile Formulations
Ashe Krystina, Baskett Dustin
|
Sep/Oct 2018
Pg. 387-398
|
Safety Standards in Pharmaceutical Compounding, Part 3: Fire Safety
Allen W Chris, Greeson Nicole MH, Mixon William
|
Nov/Dec 2020
Pg. 451-458
|
Safer Sterile Compounding: Choosing and Using Disinfectants for the Cleanroom
Kastango Eric S, Douglass Kate, Patel Kedar, Givehchi Babak, Brister Paul, Postlewaite Jay, Taraban Laura
|
Jul/Aug 2015
Pg. 268-278
|
Basics of Compounding for Hazardous Drugs, Part 4: Developing the Hazardous Drugs List and Containment Workstations
Allen Loyd V Jr
|
Mar/Apr 2007
Pg. 149-151
|
Controlled Environment Testing Association Applications Guide for the Use of Barrier Isolators in Compounding Sterile Preparations in Healthcare Facilities, Part 1
Wagner James T
|
Mar/Apr 2006
Pg. 128-133
|
Controlled Environment Testing Association Applications Guide for the Use of Barrier Isolators in Compounding Sterile Preparations in Healthcare Facilities, Part 2
Wagner James T
|
May/Jun 2006
Pg. 208-211
|
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 4: Considerations in Selection and Use of Disinfectants and Antiseptics
Allen Loyd V Jr, Okeke Claudia C
|
Nov/Dec 2007
Pg. 492-499
|
Quality Control: (Material) Safety Data Sheets
Allen Loyd V Jr
|
Mar/Apr 2017
Pg. 118-124
|
Certification of Powder-containment Hoods for Nonsterile Compounding
Mulder Kyle, Dozzi Raphael
|
Sep/Oct 2018
Pg. 369-384
|
Technology Spotlight: Barrier Isolators
Moussa Magdy, Rahe Hank, Lo Katharine
|
Jan/Feb 2003
Pg. 42-43
|
Sterile Basics of Compounding: Contamination Control Strategies, Part 2
Summers Amy
|
Nov/Dec 2022
Pg. 497-504
|
Local Ventilation for Safe Containment in the Pharmaceutical Industry
Walters Douglas B, Ryan Ray
|
Jul/Aug 2005
Pg. 293-298
|
Sterile Basics of Compounding: Contamination Control Strategies, Part 1
Summers Amy
|
Sep/Oct 2022
Pg. 411-418
|
Compounding Using Hazardous Drugs
Lau Kellie
|
Jul/Aug 2000
Pg. 261-263
|
Safety Standards in Pharmaceutical Compounding, Part 1: The Occupational Safety and Health Administration
Greeson Nicole MH, Mixon William, Allan W Chris
|
Jul/Aug 2020
Pg. 270-276
|
Quality Control Analytical Methods: A Growing Codependency: Compounding Pharmacy and Safety
Prince Bryan, Lundeval Jeremy
|
Nov/Dec 2013
Pg. 485-489
|
| Return to Top |
